Artisan Therapeutics and Tulex Pharmaceuticals Announce Positive Phase 2a Results for ART-501, a Novel Oral Liquid Extended-Release Formulation for Autism Spectrum Disorder
Artisan and Tulex Report Positive Phase 2a Results for Autism Drug ART-501SAN DIEGO, Nov. 17, 2025 (GLOBE NEWSWIRE) -- Artisan...